US 11053310
Antibodies for the treatment of cancers
granted A61KA61K2039/505A61K47/68031
Quick answer
US patent 11053310 (Antibodies for the treatment of cancers) held by The Regents of the University of California expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K47/68031, A61K47/6849, A61K47/6851